Per accedir als documents amb el text complet, si us plau, seguiu el següent enllaç: http://hdl.handle.net/2445/46036
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Espona Fiedler, Margarita |
dc.contributor.author | Soto Cerrato, Vanessa |
dc.contributor.author | Hosseini, A. |
dc.contributor.author | Lizcano, J.M. |
dc.contributor.author | Guallar, V. |
dc.contributor.author | Quesada, Roberto |
dc.contributor.author | Gao, T. |
dc.contributor.author | Pérez Tomás, Ricardo E. |
dc.date | 2013-09-17T11:23:39Z |
dc.date | 2013-09-17T11:23:39Z |
dc.date | 2012-02-15 |
dc.date | 2013-09-17T11:23:39Z |
dc.identifier.citation | 0006-2952 |
dc.identifier.citation | 601832 |
dc.identifier.uri | http://hdl.handle.net/2445/46036 |
dc.format | 8 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier B.V. |
dc.relation | Versió postprint del document publicat a: 10.1016/j.bcp.2011.11.027 |
dc.relation | Biochemical Pharmacology, 2012, vol. 83, num. 4, p. 489-496 |
dc.relation | http://dx.doi.org/10.1016/j.bcp.2011.11.027 |
dc.rights | (c) Elsevier B.V., 2012 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Proteïnes quinases |
dc.subject | Melanoma |
dc.subject | Assaigs clínics |
dc.subject | Terapèutica |
dc.subject | Protein kinases |
dc.subject | Melanoma |
dc.subject | Clinical trials |
dc.subject | Therapeutics |
dc.title | Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: Prodigiosin vs.obatoclax |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |